Abstract
The aim of the research was to study the relationship between the level of vaspin and the thickness of the intima-media of the carotid artery (CIMT), parameters of carbohydrate and lipid metabolism, functional state of the pancreas, markers of inflammation, and to create a mathematical model for the progression of atherosclerosis in patients with type 2 diabetes mellitus (DM-2) and chronic pancreatitis (CP).
Materials and methods: Serum vaspin level in 114 people with DM-2 or CP and a combination of these diseases were obtained. The parameters of lipid and carbohydrate metabolism, inflammation and functional status of pancreas were studied. CIMT was measured by means of B-mode ultrasonography. The obtained data were processed by the methods of non-parametric statistics to study the dependence of the parameters on the group, questions of the statistical significance of differences between two unrelated groups, the tightness of the relationship between the analyzed parameters.
Results: A statistically significant (p<0.05) increase in serum vaspin levels in patients with DM-2 compared with other studied groups was obtained. A reliable correlation between vaspin, carbohydrate metabolism and CIMT was obtained, and it appeared to be dependent on the presence of comorbid pathology. The value of vaspin / tumor necrosis factor-α (TNF-α), starting from which CIMT increase is considered present, was calculated.
Conclusions: Undertaken study confirmed the positive connection of vaspin with insulin resistance markers, but also demonstrated that serum vaspin levels is positively associated with CIMT. A mathematical model for predicting the progression of atherosclerosis in patients with the studied pathology was developed. It was demonstrated that the Vaspin/TNF-α ratio can be used as a marker of early atherosclerotic lesion of vascular wall, indicating the role of vaspin in atherogenesis
Reference20 articles.
1. Kolesnikova, O. V. (2019). Сhronic pancreatitis with a special type of diabetes mellitus: issues of diagnosis, course and correction. Modern Gastroenterology, 6, 59–67. doi: http://doi.org/10.30978/mg-2019-6-59
2. Shaw, J. E., Sicree, R. A., Zimmet, P. Z. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87 (1), 4–14. doi: http://doi.org/10.1016/j.diabres.2009.10.007
3. Urbanovich, A. M., Gopher, G. I. (2014). The role of leptin in the development of ischemic ailments of the heart in ailments of type 2 diabetes mellitus with revitalization. Experimental and clinical physiology and biochemistry, 2, 58–63.
4. Urbanovich, A. M. (2015). The leptin and resistin plasma levels in patients with type 2 diabetes mellitus with different disease duration and arterial hypertension. Lviv medical journal, 21 (3), 14–18.
5. Øygarden, H. (2017). Carotid Intima‐Media Thickness and Prediction of Cardiovascular Disease. Journal of the American Heart Association, 6 (1). doi: http://doi.org/10.1161/jaha.116.005313